Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) is a transient but essential intermediate formed during the catalytic cycle of Topoisomerase II (TOP2) enzymes, which regulate DNA supercoiling, decatenation, and knotting (Pommier et al., 2016, Nature Reviews Cancer). In this complex, the TOP2 enzyme creates a double-strand break and becomes covalently linked to the 5' phosphate ends of the DNA via a tyrosyl-DNA phosphodiester bond (Deweese & Osheroff, 2009, Nucleic Acids Research). This specific DNA-protein interface is the pharmacological target for "TOP2 poisons," such as etoposide and doxorubicin, which act by stabilizing the cleavage complex and preventing the religation of the DNA strands (Nitiss, 2009, Nature Reviews Cancer). The stabilization of TOP2cc converts a necessary cellular process into a source of persistent double-strand breaks, which are recognized by the cell's DNA damage response machinery, leading to cell cycle arrest and apoptosis (StatPearls, 2023). While highly effective in treating various cancers, including leukemias and solid tumors, targeting this complex carries risks such as cardiotoxicity—often linked to TOP2B in cardiomyocytes—and the potential for secondary malignancies due to chromosomal translocations (Zhang et al., 2012, Nature Medicine).
Stabilization of the transient covalent DNA Topoisomerase II–DNA cleavage complex, which inhibits DNA religation and leads to the accumulation of double-strand breaks (Pommier et al., 2016, Nature Reviews Cancer).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) (TOP2cc).